Therapeutic Solutions International Inc
Therapeutic Solutions International, Inc. focuses on immune modulation for the treatment of various specific diseases in the United States. The company develops a range of immune-modulatory agents to cancers, schizophrenia, suicidal ideation, and traumatic brain injury, as well as for daily health. Its flagship products consist of QuadraMune, a patented synergistic blend of pterostilbene, sulfora… Read more
Therapeutic Solutions International Inc (TSOI) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2024: 0.042x
Based on the latest financial reports, Therapeutic Solutions International Inc (TSOI) has a cash flow conversion efficiency ratio of 0.042x as of September 2024.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($70.84K) by net assets ($1.68 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Therapeutic Solutions International Inc - Cash Flow Conversion Efficiency Trend (2007–2023)
This chart illustrates how Therapeutic Solutions International Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Therapeutic Solutions International Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Therapeutic Solutions International Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Diagonal Bio AB
ST:DIABIO
|
-0.084x |
|
Lancaster Resources Inc.
PINK:LANRF
|
0.125x |
|
INTERTEK GROUP
BE:IT1
|
N/A |
|
SOL S.P.A. EO 052
F:QOL
|
N/A |
|
FE BATTERY METALS CORP.
F:V95
|
N/A |
|
YANGAROO Inc
PINK:YOOIF
|
0.540x |
|
Pasinex Resources Limited
PINK:PSXRF
|
1.099x |
|
Brand Group (M.G) Ltd
TA:BRND
|
0.030x |
Annual Cash Flow Conversion Efficiency for Therapeutic Solutions International Inc (2007–2023)
The table below shows the annual cash flow conversion efficiency of Therapeutic Solutions International Inc from 2007 to 2023.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2023-12-31 | $1.28 Million | $-1.06 Million | -0.823x | -11.95% |
| 2022-12-31 | $1.38 Million | $-1.02 Million | -0.735x | -182.34% |
| 2021-12-31 | $-804.98K | $-718.92K | 0.893x | +139.49% |
| 2020-12-31 | $-1.78 Million | $-663.08K | 0.373x | +144.24% |
| 2019-12-31 | $-2.04 Million | $-310.71K | 0.153x | -41.08% |
| 2018-12-31 | $-1.81 Million | $-469.17K | 0.259x | -7.12% |
| 2017-12-31 | $-1.31 Million | $-366.72K | 0.279x | -52.64% |
| 2016-12-31 | $-654.83K | $-385.74K | 0.589x | +29.72% |
| 2015-12-31 | $-131.29K | $-59.62K | 0.454x | -82.07% |
| 2014-12-31 | $-131.29K | $-332.54K | 2.533x | +6559.21% |
| 2013-12-31 | $-575.36K | $-21.88K | 0.038x | -84.33% |
| 2012-12-31 | $-192.90K | $-46.83K | 0.243x | -26.78% |
| 2011-12-31 | $302.38K | $100.25K | 0.332x | -58.29% |
| 2010-12-31 | $-27.97K | $-22.23K | 0.795x | +30122.84% |
| 2009-12-31 | $300.25K | $-795.00 | -0.003x | +99.99% |
| 2008-12-31 | $5.62K | $-107.61K | -19.144x | -18461.68% |
| 2007-12-31 | $48.49K | $-5.00K | -0.103x | -- |